Results provide an auditable candidate resource and show that, in the evaluated benchmarks, ESM-2 sequence scores did not improve epitope prioritization beyond alignment-derived conservation, and release the auditable benchmark.
Abstract
Influenza A virus antigenic drift forces annual vaccine reformulation, motivating the search for conserved epitope candidates that could support broadly protective vaccines. We systematically screened influenza A virus sequences (H1N1, H3N2, H5N1; nine viral proteins) to define 98 conserved candidate regions, 38 of which were identical across the H1N1, H3N2, and H5N1 consensus sequences — all in the polymerase complex and nucleoprotein (PB2, PB1, PA, NP) — whereas the ten surface-glycoprotein (HA/NA) candidates were subtype-specific. We then benchmarked two protein-language-model (ESM-2) features against alignment conservation. Group-masked log-probability correlated moderately with MSA conservation (Spearman ρ = 0.25–0.39 for HA) but provided no incremental value for T-cell epitope discrimination (ΔAUROC +0.004, p = 0.46); attention-derived contact-density was not a valid solvent-accessibility proxy. A curated antibody-epitope benchmark (22 clusters, 5 neutralization-supported) was underpowered for a high-confidence B-cell test. We document data-quality and reproducibility pitfalls (length heterogeneity, coordinate mapping, and pseudoreplication) and release the auditable benchmark. These results provide an auditable candidate resource and show that, in the evaluated benchmarks, ESM-2 sequence scores did not improve epitope prioritization beyond alignment-derived conservation.
It is demonstrated that an integrated generation–selection strategy can enhance vaccine coverage across current and future A(H3N2) seasons and may be applicable to other influenza subtypes.
Victoria R. Howard, James D. Allen, Matthew H. Thomas et al.· bioRxiv· 0 citations
Usutu virus is an emerging mosquito-borne flavivirus with an expanding geographic distribution and increasing public health relevance, yet no licensed vaccine is currently available. This study used an integrated reverse vaccinology strategy to identify conserved immunogenic regions from the Envelope protein and NS5 pr...
Reem Alromaihi, H. Alharbi, S. Almerdasi et al.· Microorganisms· 0 citations
Human metapneumovirus (HMPV) is a primary cause of global respiratory infections yet no approved vaccine currently exists. This study computationally predicts a multi-epitope vaccine candidate using a diverse dataset of 65 HMPV sequences spanning five continents. Following the screening of lead proteins for antigenicit...
N. Alam, Moumita Chakrabarty, Tanmoy Debnath et al.· PLoS ONE· 0 citations
The H5N1 avian influenza virus poses a significant threat to both animal and human health, with a high potential for triggering a global pandemic. This study outlines a step-by-step immunoinformatics-driven approach to design a multi-epitope vaccine against H5N1. Potential vaccine candidates were identified by analyz...
Ankita Singh, Omer S. Alkhnbashi, Filippo Castiglione· Frontiers in Applied Mathema...· 0 citations
Rift Valley fever virus (RVFV) is a major zoonotic pathogen causing significant outbreaks in humans and livestock, with no licensed effective vaccines currently available. This study employed reverse vaccinology and immunoinformatics approaches to design three multi-epitope mRNA vaccine candidates against RVFV. Conserv...
E. K. Oladipo, James Akinwumi Ogunniran, Biobele Winner Sokari et al.· Discover Immunity· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.